Amphista Therapeutics Achieves First Discovery Milestone in Collaboration with Bristol Myers Squibb

Nicola Thompson, CEO of Amphista, said, "We are absolutely delighted with the progress and success of our collaboration with BMS. Our ability to deliver ou...

May 05, 2023 | Friday | News
Galmed Pharmaceuticals forms a Strategic Partnership with OnKai

OnKai, a US-based technology company, combines public healthcare and medical innovation experience with complex process digitalization, design thinking, an...

May 05, 2023 | Friday | News
Moderna and Merck's Neoantigen Therapy, mRNA-4157, Shows Superior Survival in High-Risk Stage III/IV Melanoma Patients Compared to KEYTRUDA

mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients...

May 04, 2023 | Thursday | News
Bolivian & Taiwanese Experts Discuss Med-Tech to Position Bolivia as Robotic Neurosurgery Leader

"The Future of Robotic Surgery," over 400 medical specialists gathered to participate in a dynamic exchange of ideas and insights. The ...

May 04, 2023 | Thursday | News
MIVI Q™ Revascularization System Clinical Trial for Stroke Treatment Completes Enrollment

The EVAQ Trial enrolled 121 patients at 17 centers globally. Data from the study will be used as part of an application to the U.S. Food and Drug Administr...

May 04, 2023 | Thursday | News
New ACR Breast Cancer Screening Guidelines call for earlier and more-intensive screening for high-risk women

Other Notable Updates:   New American College of Radiology® (ACR®) breast cancer screening guidelines now call for all women &mdas...

May 04, 2023 | Thursday | News
10x Genomics Reports First Quarter 2023 Financial Results

Recent Highlights Revenue was $134.3 million for the first quarter, representing a 17% increase over the corresponding period of 2022. Surpassed 5,000 ...

May 04, 2023 | Thursday | News
Agilent Launches High-Capacity Headspace Sampler for Intelligent GC Systems

Agilent Technologies Inc. (NYSE: A) announced the release of the Agilent 8697 Headspace Sampler -XL Tray with 120 vial capacity. Customers now have the cho...

May 04, 2023 | Thursday | News
EirGenix's EG1206A Meets Phase 1 Trial Objectives as Breast Cancer Biosimilar

EG1206A is a biosimilar drug of the second-generation HER2-positive antibody drug Perjeta® (pertuzumab). EG1206A has a unique binding mechanism for HER...

May 03, 2023 | Wednesday | News
Eppendorf and Clustermarket Partner for Seamless Integration of Lab Management Tools

With research and development being a time-consuming industry, there is a constant need for time-saving digital solutions and tools. Nowadays, most laborat...

May 03, 2023 | Wednesday | News
Cytiva, Pall Life Sciences Complete Integration to Create Biotech Innovation Leader

Combined broad and differentiated portfolio with trusted technologies and commercial and service organizations Customers will have simpler and greater a...

May 03, 2023 | Wednesday | News
Genomic Urine Test Detects Bladder Cancer from DNA Up to 12 Years Before Clinical Signs and Symptoms Appear

A new genomic urine test can help doctors accurately predict bladder cancer as many as 12 years before clinical signs and symptoms emerge and long before a...

May 02, 2023 | Tuesday | News
Curasight and Curium announce global partnership for uTRACE® in prostate cancer

Curasight to develop its proprietary uTRACE® PET imaging technology to obtain regulatory approval in EU and USA, with Curium responsible for man...

May 02, 2023 | Tuesday | News
Nanox.ARC Imaging System Receives FDA Clearance, Pioneering a New Era in Medical Imaging

NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has received a ...

May 02, 2023 | Tuesday | Regulatory

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close